ARCHIVES

Klausner, Nathan Discuss Challenge of Cancer Research In the “Post-Genome World”

This article is from The Cancer Letter archive.

Vol. 25 No. 02 | January 15, 1999

Download PDF Visit The Full Archive

Related Articles

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

January 14, 1977

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010

New Government-Wide Regulatory Policy Set For Carcinogens; Industry Group Says They are Not Scientific

October 5, 1979

Clearinghouse Exec. Secty, Says It Has Failed in Its Objectives, Recommends It Be Dropped

January 13, 1978

Two Breast Cancer Treatments Show Similar Benefit In Trial

December 30, 2005